These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 21139581)
1. The role of tumour-derived iNOS in tumour progression and angiogenesis. Kostourou V; Cartwright JE; Johnstone AP; Boult JK; Cullis ER; Whitley G; Robinson SP Br J Cancer; 2011 Jan; 104(1):83-90. PubMed ID: 21139581 [TBL] [Abstract][Full Text] [Related]
2. Investigating the role of tumour cell derived iNOS on tumour growth and vasculature in vivo using a tetracycline regulated expression system. Papaevangelou E; Whitley GS; Johnstone AP; Robinson SP; Howe FA Int J Cancer; 2016 Jun; 138(11):2678-87. PubMed ID: 26756734 [TBL] [Abstract][Full Text] [Related]
4. Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas. Boult JK; Walker-Samuel S; Jamin Y; Leiper JM; Whitley GS; Robinson SP J Pathol; 2011 Nov; 225(3):344-52. PubMed ID: 21590769 [TBL] [Abstract][Full Text] [Related]
5. Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126. Cullis ER; Kalber TL; Ashton SE; Cartwright JE; Griffiths JR; Ryan AJ; Robinson SP Microvasc Res; 2006 Mar; 71(2):76-84. PubMed ID: 16530791 [TBL] [Abstract][Full Text] [Related]
6. The homeoprotein DLX4 controls inducible nitric oxide synthase-mediated angiogenesis in ovarian cancer. Trinh B; Ko SY; Haria D; Barengo N; Naora H Mol Cancer; 2015 Apr; 14():97. PubMed ID: 25924901 [TBL] [Abstract][Full Text] [Related]
7. Assessment of the direct effects of DDAH I on tumour angiogenesis in vivo. Papaevangelou E; Boult JKR; Whitley GS; Robinson SP; Howe FA Angiogenesis; 2018 Nov; 21(4):737-749. PubMed ID: 29721731 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma. Wang C; Li Y; Chen H; Zhang J; Zhang J; Qin T; Duan C; Chen X; Liu Y; Zhou X; Yang J Cancer Lett; 2017 Aug; 402():131-141. PubMed ID: 28602979 [TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic activity of endostatin inhibits C6 glioma growth. Peroulis I; Jonas N; Saleh M Int J Cancer; 2002 Feb; 97(6):839-45. PubMed ID: 11857365 [TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Hara A; Okayasu I Acta Neuropathol; 2004 Jul; 108(1):43-8. PubMed ID: 15088099 [TBL] [Abstract][Full Text] [Related]
11. In vivo detection of inducible nitric oxide synthase in rodent gliomas. Towner RA; Smith N; Doblas S; Garteiser P; Watanabe Y; He T; Saunders D; Herlea O; Silasi-Mansat R; Lupu F Free Radic Biol Med; 2010 Mar; 48(5):691-703. PubMed ID: 20034558 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Saleh M; Stacker SA; Wilks AF Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597 [TBL] [Abstract][Full Text] [Related]
13. GSK-3β regulates tumor growth and angiogenesis in human glioma cells. Zhao P; Li Q; Shi Z; Li C; Wang L; Liu X; Jiang C; Qian X; You Y; Liu N; Liu LZ; Ding L; Jiang BH Oncotarget; 2015 Oct; 6(31):31901-15. PubMed ID: 26388612 [TBL] [Abstract][Full Text] [Related]
14. Expression of NOS and VEGF in feline mammary tumours and their correlation with angiogenesis. Islam MS; Matsumoto M; Hidaka R; Miyoshi N; Yasuda N Vet J; 2012 Jun; 192(3):338-44. PubMed ID: 22154426 [TBL] [Abstract][Full Text] [Related]
15. Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness. Saidi A; Hagedorn M; Allain N; Verpelli C; Sala C; Bello L; Bikfalvi A; Javerzat S Int J Cancer; 2009 Sep; 125(5):1054-64. PubMed ID: 19431143 [TBL] [Abstract][Full Text] [Related]
16. Glioma tumourgenicity is decreased by iNOS knockout: experimental studies using the C6 striatal implantation glioma model. Yamaguchi S; Bell HS; Shinoda J; Holmes MC; Wharton SB; Whittle IR Br J Neurosurg; 2002 Dec; 16(6):567-72. PubMed ID: 12617238 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-driven glioma growth and vascularization in an orthotopic rat model monitored by magnetic resonance imaging. Goldbrunner RH; Bendszus M; Sasaki M; Kraemer T; Plate KH; Roosen K; Tonn JC Neurosurgery; 2000 Oct; 47(4):921-9; discussion 929-30. PubMed ID: 11014432 [TBL] [Abstract][Full Text] [Related]
18. PTK787/ZK222584, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decreases glioma growth and vascularization. Goldbrunner RH; Bendszus M; Wood J; Kiderlen M; Sasaki M; Tonn JC Neurosurgery; 2004 Aug; 55(2):426-32; discussion 432. PubMed ID: 15271251 [TBL] [Abstract][Full Text] [Related]
19. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells. Puglisi MA; Cenciarelli C; Tesori V; Cappellari M; Martini M; Di Francesco AM; Giorda E; Carsetti R; Ricci-Vitiani L; Gasbarrini A J Pathol; 2015 Aug; 236(4):479-90. PubMed ID: 25875314 [TBL] [Abstract][Full Text] [Related]
20. Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas. Farhadi MR; Capelle HH; Erber R; Ullrich A; Vajkoczy P J Neurosurg; 2005 Feb; 102(2):363-70. PubMed ID: 15739567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]